KNSA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 54.23%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $2,514,569.65

Kiniksa Pharmaceuticals Insider Trading History Chart

Kiniksa Pharmaceuticals Share Price & Price History

^$16.99

▲ +0.04 (0.24%)

As of 04/18/2024 11:22 AM ET

Days: 30 | 90 | 365

Top 5 Tech Stocks to Buy for 2024

From Daily Market Alerts | Ad

Elon Musk just Triggered a BOOM in These Stocks Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk.

Click here to sign up for our free report & newsletter

Kiniksa Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/6/2024	Sanj K Patel	CEO	Sell	5,582	$21.00	$117,222.00	65,012
3/4/2024	Sanj K Patel	CEO	Sell	12,742	$21.49	$273,825.58	70,594
3/1/2024	Michael R Megna	CAO	Sell	9,659	$21.45	$207,185.55	17,588
2/28/2024	Michael R Megna	CAO	Sell	5,126	$21.79	$111,695.54	17,588
1/3/2024	Mark Ragosa	CFO	Sell	12,000	$20.00	$240,000.00	15,632
1/2/2024	Michael R Megna	CAO	Sell	16,670	$19.17	$319,563.90	17,005
12/19/2023	Michael R Megna	CAO	Sell	9,316	$19.13	$178,215.08	17,005
12/7/2023	John F Paolini	Insider	Sell	28,600	$17.65	$504,790.00	44,892
9/5/2023	John F Paolini	Insider	Sell	400	$17.53	$7,012.00	44,892
7/25/2023	John F Paolini	Insider	Sell	29,000	$19.14	$555,060.00	41,910
11/29/2022	Barry D. Quart	Director	Sell	21,959	$16.15	$354,637.85

Top 5 Tech Stocks to Buy for 2024

From Daily Market Alerts | Ad

Elon Musk just Triggered a BOOM in These Stocks Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk.

Click here to sign up for our free report & newsletter

SEC Filings (Institutional Ownership Changes) for Kiniksa Pharmaceuticals (NASDAQ:KNSA)

53.95% of Kiniksa Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Kiniksa Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/17/2024	Hennion & Walsh Asset Management Inc.	124,878	$2.46M	0.1%	+29.2%	0.177%
4/5/2024	Los Angeles Capital Management LLC	139,850	$2.76M	0.0%	-5.0%	0.198%
3/21/2024	Healthcare of Ontario Pension Plan Trust Fund	227,500	$3.99M	0.0%	-6.2%	0.322%
3/11/2024	Vanguard Group Inc.	2,965,299	$52.01M	0.0%	+0.2%	4.200%
3/1/2024	Goldman Sachs Group Inc.	909,212	$15.95M	0.0%	+5.0%	1.293%
2/15/2024	Mercer Global Advisors Inc. ADV	18,784	$0.33M	0.0%	+9.5%	0.027%
2/15/2024	Virtus ETF Advisers LLC	19,132	$0.34M	0.2%	+3.6%	0.027%
2/15/2024	Legal & General Group Plc	25,068	$0.44M	0.0%	+3.9%	0.036%
2/15/2024	Vanguard Group Inc.	2,965,299	$52.01M	0.0%	+0.2%	4.216%
2/15/2024	Nuveen Asset Management LLC	411,024	$7.21M	0.0%	-27.1%	0.584%
2/15/2024	Opaleye Management Inc.	37,500	$0.64M	0.2%	N/A	0.053%
2/15/2024	Profund Advisors LLC	15,888	$0.28M	0.0%	-32.4%	0.023%
2/15/2024	Parkman Healthcare Partners LLC	615,693	$10.80M	1.5%	+20.8%	0.875%
2/15/2024	Granahan Investment Management LLC	722,388	$12.67M	0.4%	+35.2%	1.027%
2/15/2024	Healthcare of Ontario Pension Plan Trust Fund	227,500	$3.99M	0.0%	-6.2%	0.323%
2/14/2024	Royal Bank of Canada	11,588	$0.20M	0.0%	+64.3%	0.016%
2/14/2024	ADAR1 Capital Management LLC	105,000	$1.84M	0.7%	N/A	0.149%
2/14/2024	Altitude Crest Partners Inc.	456,041	$8M	5.4%	N/A	0.648%
2/14/2024	Cubist Systematic Strategies LLC	35,916	$0.63M	0.0%	N/A	0.051%
2/14/2024	Putnam Investments LLC	39,486	$0.69M	0.0%	-3.1%	0.056%
2/14/2024	Balyasny Asset Management L.P.	46,289	$0.81M	0.0%	N/A	0.066%
2/14/2024	Rubric Capital Management LP	2,907,501	$51M	1.1%	-5.5%	4.133%
2/13/2024	Envestnet Asset Management Inc.	14,509	$0.25M	0.0%	-54.9%	0.021%
2/13/2024	Northern Trust Corp	300,124	$5.26M	0.0%	+1.4%	0.427%
2/13/2024	Tower Research Capital LLC TRC	10,292	$0.18M	0.0%	+701.6%	0.015%
2/13/2024	Goldman Sachs Group Inc.	909,212	$15.95M	0.0%	+5.0%	1.293%
2/13/2024	Rafferty Asset Management LLC	95,855	$1.68M	0.0%	-31.1%	0.136%
2/13/2024	Campbell & CO Investment Adviser LLC	23,182	$0.41M	0.0%	-27.3%	0.033%
2/13/2024	California State Teachers Retirement System	30,287	$0.53M	0.0%	-4.3%	0.043%
2/9/2024	Trexquant Investment LP	71,550	$1.26M	0.0%	-6.9%	0.102%
2/9/2024	UBS Group AG	85,416	$1.50M	0.0%	+36.0%	0.121%
2/9/2024	Dynamic Technology Lab Private Ltd	12,160	$0.21M	0.0%	N/A	0.017%
2/8/2024	Janney Montgomery Scott LLC	24,903	$0.44M	0.0%	N/A	0.035%
2/8/2024	Essex Investment Management Co. LLC	171,890	$3.02M	0.6%	-7.5%	0.244%
2/8/2024	Massachusetts Financial Services Co. MA	75,650	$1.33M	0.0%	-3.1%	0.108%
2/7/2024	Principal Financial Group Inc.	41,332	$0.73M	0.0%	-7.6%	0.059%
2/7/2024	Dimensional Fund Advisors LP	349,753	$6.14M	0.0%	-6.4%	0.497%
2/7/2024	QRG Capital Management Inc.	16,010	$0.28M	0.0%	+11.7%	0.023%
2/7/2024	Jump Financial LLC	54,220	$0.95M	0.0%	N/A	0.077%
2/7/2024	BNP Paribas Financial Markets	76,668	$1.35M	0.0%	+11.4%	0.109%
2/6/2024	Charles Schwab Investment Management Inc.	156,741	$2.75M	0.0%	-24.3%	0.223%
2/6/2024	M&T Bank Corp	36,412	$0.64M	0.0%	-1.6%	0.052%
2/6/2024	Los Angeles Capital Management LLC	147,182	$2.58M	0.0%	+1.1%	0.209%
2/6/2024	Swiss National Bank	55,600	$0.98M	0.0%	-8.4%	0.079%
2/5/2024	Victory Capital Management Inc.	14,653	$0.26M	0.0%	+45.0%	0.021%
2/1/2024	Linden Thomas Advisory Services LLC	114,550	$2.01M	0.4%	-1.2%	0.163%
2/1/2024	New York State Common Retirement Fund	34,867	$0.61M	0.0%	+148.6%	0.050%
1/30/2024	Strs Ohio	33,300	$0.58M	0.0%	-5.4%	0.047%
1/25/2024	Allspring Global Investments Holdings LLC	51,616	$0.91M	0.0%	-16.1%	0.073%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	19,782	$0.35M	0.0%	-5.5%	0.028%
1/24/2024	China Universal Asset Management Co. Ltd.	4,097	$72K	0.0%	+349.7%	0.006%
1/12/2024	SG Americas Securities LLC	17,725	$0.31M	0.0%	N/A	0.025%
12/18/2023	Vanguard Group Inc.	2,958,957	$51.40M	0.0%	-4.2%	4.207%
12/7/2023	Hudson Bay Capital Management LP	302,500	$5.25M	0.0%	-55.5%	0.430%
11/30/2023	American Century Companies Inc.	20,989	$0.37M	0.0%	+87.3%	0.030%
11/24/2023	Deutsche Bank AG	91,726	$1.59M	0.0%	+2.5%	0.130%
11/16/2023	Morgan Stanley	1,491,489	$25.91M	0.0%	+14.0%	2.120%
11/15/2023	Tejara Capital Ltd	35,000	$0.61M	0.3%	+3.2%	0.050%
11/15/2023	Mercer Global Advisors Inc. ADV	17,158	$0.30M	0.0%	-26.1%	0.024%
11/15/2023	GSA Capital Partners LLP	63,216	$1.10M	0.1%	+81.9%	0.090%
11/15/2023	Sei Investments Co.	20,819	$0.36M	0.0%	N/A	0.030%
11/15/2023	Alps Advisors Inc.	71,103	$1.24M	0.0%	+38.3%	0.101%
11/15/2023	Ameriprise Financial Inc.	346,867	$6.03M	0.0%	-6.6%	0.493%
11/15/2023	AQR Capital Management LLC	323,578	$5.62M	0.0%	-36.7%	0.460%
11/14/2023	Lazard Asset Management LLC	3,502	$60K	0.0%	N/A	0.005%
11/14/2023	Schonfeld Strategic Advisors LLC	208,500	$3.62M	0.0%	+180.1%	0.296%
11/14/2023	Rubric Capital Management LP	3,077,449	$53.46M	2.0%	-8.9%	4.375%
11/14/2023	California State Teachers Retirement System	31,646	$0.55M	0.0%	-9.4%	0.045%
11/14/2023	Qube Research & Technologies Ltd	76,937	$1.34M	0.0%	-35.8%	0.109%
11/14/2023	Trexquant Investment LP	76,823	$1.33M	0.0%	-10.8%	0.109%
11/14/2023	Profund Advisors LLC	23,506	$0.41M	0.0%	+7.8%	0.033%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	256,932	$4.46M	0.0%	+59.9%	0.365%
11/13/2023	Northern Trust Corp	296,119	$5.14M	0.0%	+2.7%	0.421%
11/13/2023	EAM Investors LLC	124,438	$2.16M	0.4%	N/A	0.177%
11/13/2023	Dark Forest Capital Management LP	65,029	$1.13M	0.1%	N/A	0.092%
11/13/2023	Acadian Asset Management LLC	226,181	$3.92M	0.0%	+916.6%	0.322%
11/13/2023	Invesco Ltd.	212,596	$3.69M	0.0%	N/A	0.302%
11/13/2023	WINTON GROUP Ltd	22,504	$0.39M	0.0%	N/A	0.032%
11/13/2023	Envestnet Asset Management Inc.	32,186	$0.56M	0.0%	-37.9%	0.046%
11/13/2023	QRG Capital Management Inc.	14,331	$0.25M	0.0%	N/A	0.020%
11/13/2023	Rafferty Asset Management LLC	139,106	$2.42M	0.0%	+16.5%	0.198%
11/9/2023	Rhumbline Advisers	63,133	$1.10M	0.0%	+6.5%	0.090%
11/9/2023	Deutsche Bank AG	91,726	$1.59M	0.0%	+2.5%	0.131%
11/9/2023	Essex Investment Management Co. LLC	185,853	$3.23M	0.5%	-1.3%	0.265%
11/9/2023	UBS Group AG	62,814	$1.09M	0.0%	+40.7%	0.090%
11/8/2023	Campbell & CO Investment Adviser LLC	31,895	$0.55M	0.1%	-44.3%	0.045%
11/8/2023	Charles Schwab Investment Management Inc.	206,983	$3.60M	0.0%	-5.5%	0.295%
11/8/2023	Massachusetts Financial Services Co. MA	78,042	$1.36M	0.0%	-3.7%	0.111%
11/7/2023	Virtus ETF Advisers LLC	18,461	$0.32M	0.2%	-11.5%	0.026%
11/7/2023	Barclays PLC	175,525	$3.05M	0.0%	+7.9%	0.250%
11/6/2023	Los Angeles Capital Management LLC	145,642	$2.53M	0.0%	-9.2%	0.208%
11/6/2023	Victory Capital Management Inc.	10,106	$0.18M	0.0%	N/A	0.014%
11/4/2023	Capula Management Ltd	51,340	$0.89M	0.0%	N/A	0.073%
11/2/2023	Rice Hall James & Associates LLC	650,366	$11.30M	0.7%	-1.5%	0.927%
11/2/2023	Principal Financial Group Inc.	44,724	$0.78M	0.0%	N/A	0.064%
11/2/2023	M&T Bank Corp	37,013	$0.64M	0.0%	-35.4%	0.053%
10/27/2023	Hennion & Walsh Asset Management Inc.	55,047	$0.96M	0.1%	+89.5%	0.078%
10/27/2023	Allspring Global Investments Holdings LLC	61,532	$1.07M	0.0%	-83.2%	0.088%
10/26/2023	Strs Ohio	35,200	$0.61M	0.0%	-5.6%	0.050%
10/24/2023	Bank of New York Mellon Corp	146,568	$2.55M	0.0%	+13.8%	0.209%

Data available starting January 2016

Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody inhibitor that completed Phase II clinical trials for the treatment of giant cell arteritis; Vixarelimab, a monoclonal antibody, that is in Phase 2b clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-404, a monoclonal antibody inhibitor of the CD40- CD154 interaction, a T-cell co-stimulatory signal critical for B-cell maturation, immunoglobulin class switching, and type 1 immune response. The company was incorporated in 2015 and is based in Hamilton, Bermuda.

Today's Range

Now: $16.99

$16.80

$16.99

50 Day Range

MA: $19.58

$16.95

$21.74

52 Week Range

Now: $16.99

$10.65

$22.09

Volume

29,334 shs

Average Volume

395,695 shs

Market Capitalization

$1.20 billion

P/E Ratio

94.39

Dividend Yield

N/A

Beta

0.27

Who are the company insiders with the largest holdings of Kiniksa Pharmaceuticals?: Kiniksa Pharmaceuticals' top insider shareholders include:
Sanj K Patel (CEO)
John F Paolini (Insider)
Michael R Megna (CAO)
Mark Ragosa (CFO)
Barry D Quart (Director)
Learn More about top insider investors at Kiniksa Pharmaceuticals.
Who are the major institutional investors of Kiniksa Pharmaceuticals?: Kiniksa Pharmaceuticals' top institutional shareholders include:
Los Angeles Capital Management LLC — 0.20%
Hennion & Walsh Asset Management Inc. — 0.18%
Learn More about top institutional investors of Kiniksa Pharmaceuticals stock.
Which major investors are selling Kiniksa Pharmaceuticals stock?: During the last quarter, KNSA stock was sold by these institutional investors:
Los Angeles Capital Management LLC
During the previous year, company insiders that have sold Kiniksa Pharmaceuticals company stock include:
Sanj K Patel (CEO)
John F Paolini (Insider)
Michael R Megna (CAO)
Mark Ragosa (CFO)
Learn More investors selling Kiniksa Pharmaceuticals stock.
Which major investors are buying Kiniksa Pharmaceuticals stock?: In the previous quarter, KNSA stock was bought by institutional investors including:
Hennion & Walsh Asset Management Inc.